SEC Comment Letter for IMMUNOGEN INC (CIK 0000855654) — Sep 28, 2005

IMMUNOGEN INC (CIK 0000855654)
Date: Sept. 28, 2005 · CIK: 0000855654 · Accession: 0000000000-05-050099

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-17999

Date

August 2, 2005

Author

Joel N. Parker

Form

UPLOAD

Company

IMMUNOGEN INC (CIK 0000855654)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 August 2, 2005 Mr. Daniel Junius Senior Vice President and Chief Financial Officer ImmunoGen, Inc. 128 Sidney Street Cambridge, MA 02139

Re: ImmunoGen, Inc. Form 10-K for the fiscal year ended June 30, 2004 Forms 10-Q for the periods ended September 30, 2004, December 31, 2004 and March 31, 2005 File No. 000-17999

Dear Mr. Junius:

We have completed our review of your Form 10-K and related filings and have no further comments at this time.

Sincerely,
Joel N. Parker
Accounting Branch Chief

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Via Facsimile and U.S. Mail
Mail Stop 6010

August 2, 2005

Mr. Daniel Junius
Senior Vice President and Chief Financial Officer
ImmunoGen, Inc.
128 Sidney Street
Cambridge, MA 02139

Re:	ImmunoGen, Inc.
	Form 10-K for the fiscal year ended June 30, 2004
Forms 10-Q for the periods ended September 30, 2004, December 31,
2004 and March 31, 2005
	File No. 000-17999

Dear Mr. Junius:

	We have completed our review of your Form 10-K and related
filings and have no further comments at this time.

								Sincerely,

      Joel N. Parker
								Accounting Branch Chief

</TEXT>
</DOCUMENT>

SecProbe.io